Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
Chief Tech/Sci/R&D Officer - 17/07/2009
Director of Finance/CFO 60 01/07/2022
Director TitleAgeSince
Director/Board Member 58 09/07/2020
Chairman 68 09/12/2021
Director/Board Member 78 01/09/2004
Date Insider Type Main position Quantity % Market Cap. Importance
09/07/20 Tender

Chief Executive Officer

29,206 0.1196%
09/07/20 Tender

Chief Financial Officer

500 0.0020% -
09/07/20 Tender

Director

1,02,200 0.4187%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.84% - - 14.13L
+1.66%+2.26%-14.94%+14.02% 18TCr
-4.54%-4.83%-20.78%+11.32% 12TCr
-0.05%+1.85%+6.82%+38.88% 12TCr
+3.84%+2.21%-42.03%+10.05% 9.14TCr
+1.42%+1.95%-1.10%+82.01% 6.31TCr
-0.46%+0.42%+8.19%+82.97% 5.58TCr
+0.03%-0.68%+10.13%-21.32% 5.4TCr
-0.30%+2.48%-8.63%+44.87% 4.54TCr
+0.99%+2.55%-0.54%-5.92% 3.44TCr
Average +0.27%+0.48%-6.99%+28.54% 8.48TCr
Weighted average by Cap. +0.28%+0.76%-10.08%+26.08%
Logo TearLab Corporation
TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.
Employees
-